Founded in 2018 by a team of life sciences experts with decades of experience in both human and animal
health, Mizner Bioscience’s mission is to “discover the overlooked”— whether that’s a better delivery system, an improved dosage form, a new indication for a proven therapy, or a way to make medication and treatment more affordable.
It’s no secret that certain brand-name pet medications can be expensive. Generic medications are known for being less expensive than the name-brand versions. More importantly, approved generic medications are required by the FDA to be bioequivalent to their brand name counterparts. This holds true for pet medications as well. Generic pet medications are held to the same standards for safety, effectiveness, strength, stability, and quality that govern the brand names. The only difference is the cost, but they are equally dose appropriate.
We leverage an integrated, in-house team of regulatory, clinical and development professionals, as well as a strong network of CMO and API manufacturers to deliver innovative, cost effective solutions for our veterinary partners.